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diagnostic test, should be judged on its incremental value above and
beyond existing tests, or by the demonstration of a lower cost with
at least equal diagnostic and prognostic value. The fact that EBCT
has relatively low cost does not necessarily mean that it is also a
cost-efficient technique. The study by Shavelle et al. (1) does not
include a cost-efficiency analysis, and until newer data are available,
the clinical role of EBCT (or EBCT plus treadmill ECG) for
evaluation of patients with suspected CAD remains uncertain.
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Evaluating Coronary Artery Disease—
Where Does EBCT Fit In?
We congratulate Shavelle et al. (1) on their study in which they
present data comparing the use of electron beam computed
tomography (EBCT), treadmill-electrocardiogram (ECG) and
technetium-stress testing to identify patients with coronary artery
disease (CAD). The investigators conclude that EBCT has a
higher diagnostic ability than either treadmill-ECG or
technetium-stress for the detection of CAD. There are several
important issues, however, that should be addressed when inter-
preting the results of their study.
First, it is important to note that the authors chose to study a
high-risk population in which 69% of patients had CAD. In most
populations undergoing screening tests, the disease prevalence is
much lower. Some diagnostic test characteristics are affected by
disease prevalence, including positive and negative predictive
values and accuracy. Consequently, studies of diagnostic tests often
present predictive values and accuracy that are calculated for
lower-risk populations, as well as likelihood ratios that are inde-
pendent of disease prevalence. Using data from the report by
Shavelle et al., we calculated predictive values and accuracy using a
lower disease prevalence than the one reported in their paper
(Table 1). Moreover, we calculated likelihood ratios for the three
diagnostic tests. Positive predictive values for the three tests were
similarly poor, suggesting that each of these tests has a poor
diagnostic value for CAD in low-risk populations. At the same
time, EBCT had the highest negative predictive value (98%),
suggesting that the strength of EBCT lies in its ability to rule out
CAD. When we calculated the accuracy of each of the three tests,
using a more typical disease prevalence, EBCT was the least
accurate. However, EBCT had the best negative likelihood ratio,
reaffirming its strength in ruling out CAD. When we calculated
positive likelihood ratios, technetium-stress testing was somewhat
better at identifying patients with CAD. Thus, EBCT may not be
the ideal test to identify patients with CAD in a general population.
A second issue is that the investigators’ study may be limited by
the sensitivity and specificity they found for technetium-stress
testing. The numbers that they report are lower than those found
in previous studies. Because the investigators examined only 97
patients, they may have inadvertently underestimated the sensitiv-
Table 1. Diagnostic Test Characteristics of Treadmill-ECG, Technetium-Stress, Exercise Echocardiography and EBCT for Patients
With a High and Low Risk of CAD
Sensitivity
(%)
Specificity
(%)
Accuracy
(%)
Positive
Predictive
Value (%)
Negative
Predictive
Value (%)
Positive
Likelihood
Ratio
Negative
Likelihood
Ratio
Study Population (disease prevalence 5 69%)
Treadmill-ECG 76 60 71 81 53 1.9 0.4
Technetium-stress 78 67 74 83 57 2.4 0.3
EBCT 96 47 80 80 82 1.8 0.1
Typical Population (disease prevalence 5 20%)
Treadmill-ECG 76 60 63 32 91 1.9 0.4
Technetium-stress 78 67 69 37 92 2.4 0.3
EBCT 96 47 57 31 98 1.8 0.1
Typical Population (disease prevalence 5 20%)
Technetium-stress* 87 64 69 38 95 2.4 0.2
Exercise-echocardiography* 85 77 79 48 95 3.7 0.2
*Assuming sensitivity and specificity from meta-analysis (2).
CAD 5 coronary artery disease; EBCT 5 electron beam computed tomography; ECG 5 electrocardiogram.
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ity and specificity of technetium-stress testing. The authors refer to
a meta-analysis of studies examining exercise nuclear testing (2). In
this pooled analysis, nuclear testing had a sensitivity of 87% and a
specificity of 64%. Using this sensitivity and specificity, and
assuming a disease prevalence of 20%, we calculated a positive
predictive value of 38%, a negative predictive value of 95% and an
accuracy of 69% for technetium-stress testing. The positive like-
lihood ratio was 2.4, and the negative likelihood ratio was 0.2.
Thus, when the diagnostic test characteristics are recalculated
using the higher sensitivity and specificity from the literature, it
appears that technetium-stress testing may be a better screening
test than EBCT to identify patients with CAD.
A third issue is that the meta-analysis (2) referred to by Shavelle
et al. (1) also published test characteristics for exercise echocardi-
ography, reporting a pooled sensitivity and specificity of 85% and
77%, respectively. Using these data, we calculated the diagnostic
test characteristics for exercise echocardiography in a population
with a disease prevalence of 20% (Table 1). The positive and
negative predictive values were 48% and 95%, respectively; accu-
racy was 79%; and the positive and negative likelihood ratios were
3.7 and 0.2, respectively. Thus, using the pooled sensitivity and
specificity from the literature, exercise echocardiography may well
be the best of the four diagnostic tests.
Finally, because of the relatively small number of patients
studied by Shavelle et al., it would have been helpful if the authors
had included 95% confidence intervals (CIs) for the diagnostic test
characteristics they cited. Although the point estimates they
reported suggest that EBCT has reasonable test characteristics,
CIs for these numbers may be wide, and there may be no
statistically significant difference among the various diagnostic
tests.
In conclusion, EBCT has several important limitations when
used for the diagnosis of CAD. It is a costly procedure, and it
provides no information regarding the functional significance of
any lesions that may be present. Before EBCT is widely employed
as a screening test for CAD, the evidence in favor of this test must
be carefully scrutinized. Investigators should report on diagnostic
test characteristics in populations where the disease prevalence is
reflective of the populations in which the tests will eventually be
used. In addition, similar, but larger studies, need to be performed
in lower-risk populations to provide precise point estimates of
diagnostic test characteristics as well as narrow CIs for these
numbers.
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REPLY
We appreciate the comments of Drs. Sheppard and Eisenberg
regarding our recent publication evaluating the use of electron
beam computed tomography (EBCT) in symptomatic patients
undergoing exercise stress testing and coronary angiography (1).
The study population was indeed at high risk for coronary artery
disease (CAD) as all patients were symptomatic with presumed
ischemic chest pain and were referred for coronary angiography by
their treating physicians. This population would therefore not be
reflective of patients referred for EBCT to exclude the presence of
CAD. By assuming a disease prevalence of 20%, compared to the
prevalence of 69% in our study, Drs. Sheppard and Eisenberg
found EBCT to have a negative predictive value of 98%, indicating
an excellent ability to exclude CAD. Using values for sensitivity
and specificity from a meta-analysis (2), they found technetium-
stress testing to have the highest positive likelihood ratio among
the testing methods, indicating a superior ability to diagnose CAD
in this lower-risk population. We agree with these calculations and
conclusions, but we stress that our patient population was signif-
icantly different from one with a disease prevalence of 20%.
Therefore, our study did not evaluate a patient population referred
to EBCT for the purpose of screening for CAD.
A significant limitation of our report was the relatively low
sensitivity and specificity for technetium-stress testing. As outlined
in the Discussion section, possibilities for this include imaging
defects secondary to diaphragmatic and/or breast attenuation, the
lack of electrocardiograph (ECG)-gating and delayed image ac-
quisition after injection of the nuclear tracer agent. However, as
Drs. Shepard and Eisenberg point out, another significant issue is
the relatively small number of patients in our study (n 5 97),
which may be the main reason for these findings.
The suggestion that exercise echocardiography may be the best
noninvasive diagnostic test because of its highest positive likeli-
hood ratio (3.7) is possible, but this modality was not evaluated in
our study.
The 95% confidence intervals (CIs) for the characteristics of
each testing method are shown in Table 1. As Drs. Sheppard and
Eisenberg suggest, the CIs for several of the testing methods are
relatively wide. We agree that additional, larger studies are needed
to further evaluate the utility of EBCT coronary scanning.
Table 1. 95% Confidence Intervals for the Characteristics of
Each Testing Method
Testing
Method
Sensitivity
(%)
95% CI
Specificity
(%)
95% CI
Accuracy
(%)
95% CI
PPV
(%)
95% CI
NPV
(%)
95% CI
Treadmill-ECG 76 60 71 81 53
66, 88 42, 78 62, 80 71, 91 36, 70
Technetium-
stress
78 67 74 83 57
68, 88 50, 84 65, 83 74, 92 41, 73
EBCT 96 47 80 80 82
91, 100 29, 65 72, 88 71, 89 64, 100
Treadmill-ECG
and EBCT
72 83 75 91 57
61, 83 70, 96 66, 84 83, 99 42, 72
CI 5 confidence interval; EBCT 5 electron beam tomography; ECG 5 electrocar-
diograph; NPV 5 negative predictive value; PPV 5 positive predictive value.
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